-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Trevi Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
- Trevi Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$13.3M, a 58.5% decline year-over-year.
- Trevi Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$43.2M, a 39.2% decline year-over-year.
- Trevi Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$33.9M, a 13.4% decline from 2022.
- Trevi Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$29.9M, a 7.91% increase from 2021.
- Trevi Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$32.5M, a 0.04% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)